Feedback / Questions
gotistobart (BNT316) - OncoC4, BioNTech
docetaxel - Generic mfg.
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04140526
May 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next